TP53 and neoplasm: In some cancer types such as BRCA and BLCA, the TP53 phenocopies may constitute a high fraction of 19% and 16% tumor samples, respectively, suggesting that the TP53 status of tumors should preferentially be measured via a functional readout (here, transcriptome-wide signature) rather than considering only the TP53 gene mutations.